Skip to main content

Testing version — LOERadar is in active testing. Features and data may change.

Intelligence Hub News Changes Search

LOERadar

FDA drug patent and exclusivity intelligence, assembled from public records.

Sponsored by

Intelligence Hub About Terms of Service Privacy Policy Data Sources Log in

Attorney Advertising

© 2026LOERadar · An informational research tool drawn from public records; it is not a law firm, does not provide legal advice, and its use does not create an attorney-client relationship.

GYNE-SULF (TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE)) | LOERadar

Viewing data from:

GYNE-SULF

ANDA

TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE) | A088607 | COSETTE PHARMACEUTICALS NC LABORATORIES LLC

1 strength0 unique patents0 unique exclusivities

Products (1)

#001 — 3.7%;2.86%;3.42%

0 patents0 exclusivities▴

CREAM;VAGINAL | Approved: Jun 9, 1986

No patent or exclusivity listings for this strength.